Skip to content

Effect of spot urine sodium guided diuretics regimen in patients with acute decompensated heart failure

Effect of spot urine sodium guided diuretics regimen in patients with acute decompensated heart failure

Status
Unknown
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20231108001
Enrollment
50
Registered
2023-11-08
Start date
2023-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure Acute decompensated heart failure, furosemide, loop diuretic, urine sodium, urine output

Interventions

Record urine sodium to adjust furosemide dose according to the protocol,Record urine output to adjust furosemide dose according to the protocol
Experimental Other,Active Comparator Other
urine sodium arm,urine output arm

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 18-year-old with hospital admission with the principal diagnosis of acute decompensated heart failure within 24 hours of the hospital visit. 2. Presence of at least one symptoms and signs of volume overload: orthopnea, paroxysmal nocturnal dyspnea, jugular venous distension, lung crepitation.

Exclusion criteria

Exclusion criteria: 1. Hydrochlorothiazide, acetazolamide, or tolvaptan use within 48 hours prior to the enrollment period 2. Systolic blood pressure < 90 mmHg or mean arterial pressure < 65 mmHg 3. Inotrope or vasopressor usage 4. Glomerular function rate < 30 ml/min/1.73m2 5. Use of renal replacement therapy or ultrafiltration 6. Exposure to intravenous contrast agents anticipated within the next 72 hours 7. Need for invasive mechanical ventilation 8. Concurrent diagnosis of an acute coronary syndrome 9. History of cardiac transplantation and/or ventricular assist device 10. Pregnant or currently breastfeeding

Design outcomes

Primary

MeasureTime frame
Total urine output at 72 hours of the study period 72 hours after the intervention mL

Secondary

MeasureTime frame
Freedom from congestion at 72 hours of the study period Within 72 hours after the intervention Symptoms and physical examination,Length of hospital stay Until discharge from admission days,Composite end point at 1 month after hospital discharge 1 month Death from any cause, Heart failure rehospitalization, Need for renal replacement therapy

Countries

Thailand

Contacts

Public ContactChuti Burana

King Chulalongkorn Memorial Hospital

burana.chuti@gmail.com0818141250

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026